Patent · US Active

S1P3 antagonists

US11472772B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · IL

Inventors

Chiara Caramelli · Stigliano, IT
Cesare Federico · Perugia, IT
Emanuele Gabellieri · Lausanne, CH
Matteo Magnani · Pratovecchio, IT
Iolanda Micco · Colle di Val d'Elsa, IT
Georg C. Terstappen · Battenberg, DE

Key dates

Filing date	Jan 24, 2020
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.